Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
41,422,068
-
Share change
-
-347,616
-
Total reported value
-
$7,367,508,771
-
Put/Call ratio
-
171%
-
Price per share
-
$177.89
-
Number of holders
-
425
-
Value change
-
-$116,440,964
-
Number of buys
-
221
-
Number of sells
-
234
Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q3 2019
As of 30 Sep 2019,
ABIOMED INC - COMMON STOCK (ABMD) was held by
425 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,422,068 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, BAILLIE GIFFORD & CO, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, BROWN CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC.
This page lists
425
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.